Artificial intelligence tool to improve heart failure care
Science Daily - Heart Disease
MAY 14, 2024
The powerful new AI tool can predict heart failure outcomes in specific patients, helping doctors improve care.
Heart Failure Related Topics 
New Study Published in JACC: Heart Failure Reveals that Despite Significant Efforts to Improve Acute Heart Failure Treatment Over the Past 20 Years, Management Remains Unchanged
DAIC
MAY 2, 2024
(‘Reprieve’), a development stage company focused on pioneering an intelligent approach to acute decompensated heart failure (ADHF) treatment, today highlighted the publication of TREAT-AHF study results in JACC: Heart Failure. Heart failure (HF) is a leading cause of hospitalization in the United States.
Advance in the Treatment of Acute Heart Failure Identified
DAIC
APRIL 30, 2024
Getty Images milla1cf Tue, 04/30/2024 - 12:56 April 30, 2024 — A multicenter study led by Vanderbilt University Medical Center ( VUMC ) and Lipscomb University College of Pharmacy in Nashville has identified a potential new treatment for acute heart failure , a leading cause of hospitalization and death. hospitals from emergency rooms.
FDA clears 1st AI to detect heart failure
Becker's Hospital Review - Cardiology
APRIL 3, 2024
The FDA has approved an artificial intelligence algorithm for Eko Health's digital stethoscope that can detect low ejection fraction, a key indicator of heart failure.
Heart Failure 
112
112 Heart Failure 112
112 
E-Cigarettes Tied to Heart Failure
Med Page Today
APRIL 2, 2024
(MedPage Today) -- Use of electronic nicotine products was associated with incident heart failure, a prospective study found. People who self-reported ever having used electronic cigarettes (e-cigarettes) were 19% more likely to develop heart.
Heart Failure 104
104 Heart Failure 104
104 
RELIEVE-HF: Interatrial shunt in patients with heart failure
Cardiology Update
APRIL 25, 2024
RELIEVE-HF investigators evaluated the efficacy and safety of the V-wave interatrial shunt system in patients with heart failure. The primary endpoint was a composite of all-cause mortality, left ventricular assist device (LVAD)/heart transplantation, HF hospitalizations, worsening HF, and KCCQ score changes. April 6, 2024.
Advance in the treatment of acute heart failure identified
Science Daily - Heart Disease
APRIL 25, 2024
A multicenter study has identified a potential new treatment for acute heart failure, a leading cause of hospitalization and death.
Heart Failure 103
103 
New cardiac research will save women's lives by improving detection of heart failure
Science Daily - Heart Disease
MAY 15, 2024
An important new study has advanced how heart failure is detected in women -- meaning more female patients can be diagnosed and at an earlier stage.
Optimization of Evidence-Based Heart Failure Medications After an Acute Heart Failure Admission
JAMA Cardiology
DECEMBER 26, 2023
This secondary analysis of the Safety, Tolerability, and Efficacy of Rapid Optimization, Helped by N-Terminal Pro–Brain Natriuretic Peptide Testing of Heart Failure Therapies (STRONG-HF) randomized clinical trial investigates what variables are associated with success in uptitration of guideline-directed medical therapy after hospital discharge for (..)
Heart Failure 101
101 
Contemporary pharmacological treatment and management of heart failure
Nature Reviews - Cardiology
MARCH 25, 2024
Nature Reviews Cardiology, Published online: 26 March 2024; doi:10.1038/s41569-024-00997-0 In this Review, Bozkurt provides an overview of the management of patients with heart failure across the full range of left ventricular ejection fraction, derived from the recommendations in the latest US and European guidelines.
Does Ejection Fraction Make or Break Afib Ablation in Heart Failure Patients?
Med Page Today
APRIL 24, 2024
(MedPage Today) -- The efficacy of catheter ablation for heart failure (HF) patients with atrial fibrillation (Afib or AF) hinged on the phenotype of disease, researchers reported based on a meta-analysis. Compared with conventional rate or rhythm.
AFIB 98
98 
Implicity Earns FDA Clearance for New Heart Failure Prediction Algorithm
DAIC
MAY 17, 2024
Based on the Health Data Hub complete medico-administrative database and comprehensive datasets from Implicity's AI -based remote monitoring platform, the Implicity team trained and validated a machine learning algorithm that assesses the risk of future heart failure events, enabling physicians to intervene before a patient requires hospitalization.
Interatrial Shunt's Prospects in Heart Failure Shrink After RELIEVE-HF
Med Page Today
APRIL 7, 2024
(MedPage Today) -- ATLANTA -- An interatrial shunt failed to provide a clinical benefit to people with heart failure (HF) overall in the RELIEVE-HF trial, though actual harm or benefit seemed to hinge on the patient's left ventricular ejection.
Finerenone Slows CKD Progression After Heart Failure Hospitalization
HCPLive
MAY 15, 2024
A post hoc analysis from FIDELITY shows finerenone could significantly reduce eGFR slopes among patients at risk of worsening CKD due to a heart failure hospitalization.
AskBio Receives FDA Fast Track Designation for AB-1002 Investigational Gene Therapy Program in Congestive Heart Failure
DAIC
APRIL 18, 2024
Inhibiting the function of this protein, which is linked to congestive heart failure (CHF), could potentially lead to a therapeutic effect on the heart.1,2 Inhibiting the function of this protein, which is linked to congestive heart failure (CHF), could potentially lead to a therapeutic effect on the heart.1,2
In Heart Failure, Thinking Care Will Be Unaffordable May Mean Poorer Outcomes
Med Page Today
MARCH 21, 2024
(MedPage Today) -- How patients with acute decompensated heart failure (HF) perceived the financial challenges of their healthcare played out in their health outcomes, despite receiving life-prolonging medications, a prospective study from China.
Heart Failure 110
110 
Resynchronization-defibrillation for heart failure shows long-term benefits
Cardiology Update
JANUARY 22, 2024
The Resynchronization–Defibrillation for Ambulatory Heart Failure Trial (RAFT; NCT00251251 ) demonstrated a greater 5-year mortality benefit for patients receiving cardiac-resynchronization therapy (CRT) compared to those receiving implantable cardioverter–defibrillators (ICDs). The median follow-up duration for these patients was 7.7
Rethinking heart failure clinical trials: the heart failure collaboratory
Frontiers in Cardiovascular Medicine
JANUARY 23, 2024
The Heart Failure Collaboratory (HFC) is a consortium of stakeholders in the heart failure (HF) community that aims to improve the infrastructure of clinical research to promote development of novel therapies for patients.
Study links e-cigarette use with higher risk of heart failure
Medical Xpress - Cardiology
APRIL 2, 2024
People who use e-cigarettes are significantly more likely to develop heart failure compared with those who have never used them, according to one of the largest prospective studies to date investigating possible links between vaping and heart failure.
Ohio State First in Central Ohio to Use Novel Heart Failure Therapy
DAIC
FEBRUARY 26, 2024
milla1cf Mon, 02/26/2024 - 12:40 February 26, 2024 — More than 6 million Americans live with heart failure , and about half have an enlarged left ventricle, which causes stress on the heart and less blood pumped with each heartbeat. Patients may experience trouble breathing and fatigue, and at times require hospitalization.
Heart Failure 106
106 
Study shows effect of socio-economic factors that predict diabetic patients' risk of heart failure
Medical Xpress - Cardiology
APRIL 11, 2024
military veterans with diabetes to validate and modify a widely accepted model used to predict the risk of heart failure in diabetic patients. A recent study by Case Western Reserve University used national data from U.S.
Heart Failure 104
104 
FDA Clears First AI to Aid Heart Failure Detection During Routine Check-ups
DAIC
APRIL 3, 2024
healthcare providers can now detect Low EF, a key heart failure indicator, in 15 seconds using an Eko stethoscope during a routine physical examination. As a result, many heart failure cases go undiagnosed until symptoms force a specialist or emergency hospital visit, leading to worse patient outcomes and exacerbated healthcare costs.2
Heart failure trends reverse, are rising again: Study
Becker's Hospital Review - Cardiology
APRIL 25, 2024
The decadelong reduction in heart failure deaths has "been entirely undone" in recent years, according to a research letter published April 24 in JAMA Network.
Kidney dysfunction linked to heart failure with preserved ejection fraction
Medical Xpress - Cardiology
DECEMBER 20, 2023
Mild and moderate kidney dysfunction are associated with left ventricular diastolic dysfunction and heart failure with preserved ejection fraction (HFpEF), according to a study published online Nov. 27 in ESC Heart Failure.
Sacubitril/Valsartan for Worsening Heart Failure
American College of Cardiology
MARCH 20, 2024
What is the safety and efficacy of sacubitril/valsartan when initiated during hospitalization or soon after a worsening heart failure event and among patients with HF across the spectrum of ejection fraction?
The double burden: type 1 diabetes and heart failure—a comprehensive review
Cardiovascular Diabetology
FEBRUARY 11, 2024
Heart failure (HF) is increasing at an alarming rate, primary due to the rising in aging, obesity and diabetes. Notably, individuals with type 1 diabetes (T1D) face a significantly elevated risk of HF, leading.
Heart Failure 111
111 
Omecamtiv Mecarbil in the treatment of heart failure: the past, the present, and the future
Frontiers in Cardiovascular Medicine
MARCH 18, 2024
Heart failure, a prevailing global health issue, imposes a substantial burden on both healthcare systems and patients worldwide. With an escalating prevalence of heart failure, prolonged survival rates, and an aging demographic, an increasing number of individuals are progressing to more advanced phases of this incapacitating ailment.
Severe Maternal Grief Associated with Increased Risk of Heart Failure in Child
DAIC
MARCH 1, 2024
In a new study published in JACC: Heart Failure , maternal loss of a partner or child shortly before or during pregnancy was found to be associated with increased risk of heart failure up to middle-age in the child. According to the World Heart Federation, more than 64 million people worldwide have heart failure.
Selenium Deficiency Linked to Anemia in Heart Failure Patients
HCPLive
JANUARY 25, 2024
Lower levels of selenoprotein P were associated with reduced hemoglobin, greater transferrin receptor 1, and an increased prevalence of anemia in a cohort of hospitalized heart failure patients.
New study suggests target steps per day for reduced risk of heart failure
Science Daily - Heart Disease
FEBRUARY 21, 2024
In ambulatory women ages 63-99 years, higher amounts of usual daily light and moderate intensity activities were associated with lower risk of developing heart failure with preserved ejection fraction independent of demographic and clinical factors associated with heart failure risk.
This two-step screening process could reduce diabetic heart failure
Becker's Hospital Review - Cardiology
JANUARY 3, 2024
Dallas-based UT Southwestern Medical Center researchers found a two-step screening protocol combining clinical risk assessment with biomarker testing that can identify which patients with Type 2 diabetes need medication to prevent heart failure.
Heart Failure 108
108 
Deepak Bhatt, MD, MPH: Need for In-Hospital Initiation, Uptitration of GDMT in Acute Heart Failure
HCPLive
FEBRUARY 8, 2024
Deepak Bhatt, MD, MPH, discusses the need to improve in-hospital initiation and uptitration of guideline-directed medical therapy in heart failure.
Heart Failure 130
130 
Understanding Total Costs Associated with Hospitalization for Heart Failure, with Veraprapas Kittipibul, MD
HCPLive
APRIL 7, 2024
Veraprapas Kittipibul, MD, discusses a study examining costs associated with heart failure hospitalization among patients with HFrEF or HFpEF from within the GWTG-HF registry.
BioCardia Announces CMS Approval of Coverage for CardiAMP Cell Therapy Confirmatory Phase III Heart Failure Study
DAIC
MARCH 13, 2024
CMS has reviewed the CardiAMP Heart Failure II Trial and approved the investigational product, related and routine items and services for purposes of Medicare coverage. The CardiAMP Heart Failure II Trial is FDA approved to enroll up to 250 patients at up to 40 clinical centers. said Peter Altman , PhD.,
CMS 87
87 
Lives Prolonged for Longtime CRT-D Users With Heart Failure
Med Page Today
JANUARY 17, 2024
(MedPage Today) -- Eligible heart failure patients with a wide QRS complex spent more time alive after use of a cardiac resynchronization therapy defibrillator (CRT-D) compared with an implantable cardioverter-defibrillator (ICD), according to.
Heart Failure 103
103 
Efficacy and Safety of Dapagliflozin in Acute Heart Failure
American College of Cardiology
APRIL 22, 2024
The goal of the DICTATE-AHF trial was to determine the efficacy and safety of adding the sodium-glucose cotransporter-2 (SGLT2) inhibitor dapagliflozin to intravenous (IV) loop diuretic therapy in patients hospitalized with acute decompensated heart failure (ADHF).
Study reveals new connection between impaired autophagy and heart failure
Medical Xpress - Cardiology
JANUARY 11, 2024
A new study sheds light on how autophagy, the body's process for removing damaged cell parts, when impaired, can play a role in causing heart failure.
Heart Failure 105
105 
New gene discovery leads advance against a form of heart failure prevalent in men
Medical Xpress - Cardiology
APRIL 1, 2024
University of Virginia School of Medicine researchers have discovered a gene on the Y chromosome that contributes to the greater incidence of heart failure in men. The work is published in the journal Nature Cardiovascular Research.
Heart Failure 102
102 
Iron deficiency and supplementation in heart failure
Nature Reviews - Cardiology
FEBRUARY 6, 2024
Nature Reviews Cardiology, Published online: 07 February 2024; doi:10.1038/s41569-024-00988-1 In this Review, Lakhal-Littleton and Cleland use the latest understanding of iron homeostasis to evaluate existing and emerging markers of iron status, describe the reciprocal relationship between iron status and heart failure, and mechanistically examine (..)
Clinical Trial Presented at HRS 2024 Shows Benefits of Early Cardiac Resynchronization Therapy (CRT) in Slowing Progression of Heart Failure
DAIC
MAY 18, 2024
Researchers presented these findings “Late Breaking Clinical Trials and Science – CIEDs: Early Cardiac Resynchronization Therapy for Patients with Moderately Reduced Ejection Fraction and Left Bundle Branch Block” this morning during the May 16-19 meeting of the Heart Rhythm Society , HRS 2024 , being held in Boston, MA. Approximately 6.7
Smartphone-Based Recognition of Heart Failure
American College of Cardiology
APRIL 11, 2024
Can cardiac motion measured using smartphone-based seismocardiography identify patients with heart failure (HF)?
Immune checkpoints in cardiac physiology and pathology: therapeutic targets for heart failure
Nature Reviews - Cardiology
JANUARY 25, 2024
Nature Reviews Cardiology, Published online: 26 January 2024; doi:10.1038/s41569-023-00986-9 In this Review, Varga and colleagues provide an overview of the evidence on immune checkpoint inhibitor-induced heart failure and cardiac dysfunction that is unrelated to myocarditis, and discuss how pharmacological targeting of immune checkpoints might be (..)
Prognostic Models for Mortality and Morbidity in Heart Failure With Preserved Ejection Fraction
JAMA Cardiology
MARCH 26, 2024
This prognostic study investigates if models that incorporate routinely collected clinical and laboratory information can predict morbidity and mortality in patients with heart failure and preserved ejection fraction.
Case report of belt electrode-skeletal muscle electrical stimulation for acute heart failure with severe obesity: a novel therapeutic option for acute phase rehabilitation
Frontiers in Cardiovascular Medicine
MARCH 7, 2024
However, information on its efficacy and safety in patients with heart failure remains limited. Case presentation A 43-year-old man with a body mass index of 41 kg/m 2 was admitted to our hospital for acute heart failure due to dilated cardiomyopathy. No adverse events were observed during B-SES.
Heart Failure 124
124 
Let's personalize your content